Home
Drugs
Targets
Pathways
Ontologies
Cyp450s
Adv.search
Help/FAQ

Drug Details

add
Name:ALITRETINOIN
PubChem ID:449171
Pathway:-
InChI:InChI=1/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+/f/h21H
SMILES:C\C(=C(C(/[H])=C(\[H])C(\C)=C(/[H])C(O)=O)/[H])C(/[H])=C(\[H])C1=C(C)CCCC1(C)C

Properties:
Formula:C20H28O2Atoms:28
Molecular Weight:300.435Rotatable Bonds:5
H-bond Acceptors:2H-bond Donors:0
logP:5.6026
Targets:
Synonyms:
(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-n
(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid
(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid
(2E,4E.6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexan-1-yl)-2,4,6,8-nonatetraenoic acid
(9cis)-retinoic acid
2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6Z,8E)-
5300-03-8
9 Cis Retinoic Acid
9(Z)-Retinoic acid
9-cis RA
9-cis Retinoic Acid
9-cis-RA
9-Cis-Retinoic Acid
9-CIS-RETINOIC ACID (SEE RETINOID PROJECT 6)
9-cis-Tretinoin
9-CRA
9CRA
AGN 192013
AGN-192013
AIDS-060996
AIDS060996
ALITRETINOIN
Alitretinoin (USAN)
Alitretinoin [USAN]
ALRT 1057
ALRT-1057
BAL-4079
BB_NC-1005
BSPBio_001495
C15493
C20H28O2
CCRIS 7098
CHEBI:50648
HSDB 7186
IDI1_033965
LG-100057
LGD 100057
LGD 1057
LGD-1057
LMPR01090022
LS-1328
Mixture Name
NCGC00161590-01
NCGC00161590-02
NCGC00161590-03
NCGC00161590-04
NCGC00161590-05
NCGC00161590-06
NCGC00161590-07
nchembio.106-comp3
nchembio861-comp8
NSC 659772
NSC-659772
NSC659772
PANRETIN
Panretin Gel
Panretyn
Panrexin
R4643_SIGMA
REA
Retinoic acid, 9-cis-
Retinoic acid, cis-9,trans-13-
Ro-04-4079
Spectrum5_001935
STOCK1N-38565
Toctino
UPCMLD-DP097:001
UPCMLD-DP097:002
ATC-Codes: